Four molecule families have peer-reviewed clinical evidence supporting their use in microinfusion-style delivery: copper tripeptide GHK-Cu (collagen synthesis, gene-expression modulation), recombinant epidermal growth factor or sh-Oligopeptide-1 (keratinocyte proliferation, dermal restructuring), polydeoxyribonucleotide PDRN (adenosine A2A receptor activation, fibroblast stimulation, anti-melanogenesis), and a multi-molecular-weight hyaluronic acid system (50 kDa to 2000 kDa fractions, each with different penetration depth and biological role)
Zhang S, Zhou J, Li L, et al
Rush AJ, Trivedi MH, Wisniewski SR, et al
Their unique ability to stimulate collagen production, provide antioxidant protection, and enhance skin barrier function simultaneously addresses multiple aspects of the aging process in a single ingredient
This escalation approach is standard across GLP-1 class compounds and serves to improve gastrointestinal tolerability
Research Supplies for CJC-1295 Hand-picked storage, injection, and recovery supplies paired with CJC-1295 protocols